Enfusion, Inc. (ENFN)
| Previous Close | 10.99 |
| Open | 10.94 |
| Bid | 11.08 x 1000 |
| Ask | 11.18 x 1000 |
| Day's Range | 11.03 - 11.25 |
| 52 Week Range | 7.80 - 18.35 |
| Volume | |
| Avg. Volume | 406,793 |
| Market Cap | 776.094M |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Business Wire
Enfusion Names Michael Spellacy as Board Chair and Non-Executive Director
NEW YORK & LONDON & HONG KONG, January 11, 2023--Enfusion, Inc. ("Enfusion") (NYSE: ENFN), a leading provider of cloud-native software-as-a-service (SaaS) solutions for investment managers, today announced that on January 9, 2023, its Board of Directors (the "Board") had appointed Michael Spellacy, as Board Chair, effective immediately.
- Business Wire
Enfusion Names Oleg Movchan as Chief Executive Officer
NEW YORK & LONDON & HONG KONG, December 22, 2022--Enfusion, Inc. ("Enfusion") (NYSE: ENFN), a leading provider of cloud-native SaaS solutions for investment managers, today announced that its Board of Directors (the "Board") has appointed Oleg Movchan, as Chief Executive Officer, effective December 22, 2022. Mr. Movchan has been serving as Interim Chief Executive Officer since August 21, 2022.
- Business Wire
Enfusion Appoints Brad Herring as New Chief Financial Officer
NEW YORK & LONDON & HONG KONG, December 19, 2022--Enfusion, Inc. ("Enfusion") (NYSE: ENFN), a leading provider of cloud-native SaaS solutions for investment managers, today announced the appointment of Brad Herring as Chief Financial Officer.
